Literature DB >> 11751903

p21(Cip1) Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export.

Jodi R Alt1, Andrew B Gladden, J Alan Diehl.   

Abstract

There is increasing evidence that p21(Cip1) and p27(Kip1) are requisite positive regulators of cyclin D1.CDK4 assembly and nuclear accumulation. Both Cip and Kip proteins can promote nuclear accumulation of cyclin D1, but the underlying mechanism has not been elucidated. We now provide evidence that p21(Cip1) promotes the nuclear accumulation of cyclin D1 complexes via inhibition of cyclin D1 nuclear export. In vivo, we demonstrate that p21(Cip1) can inhibit glycogen synthase kinase 3 beta-triggered cyclin D1 nuclear export and phosphorylation-dependent nucleocytoplasmic shuttling. Furthermore, we find that cyclin D1 nuclear accumulation in p21/p27 null cells can be restored through inhibition of CRM1-dependent nuclear export. The ability of p21(Cip1) to inhibit cyclin D1 nuclear export correlates with its ability to bind to Thr-286-phosphorylated cyclin D1 and thereby prevents cyclin D1.CRM1 association.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751903     DOI: 10.1074/jbc.M108867200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  82 in total

1.  ERF nuclear shuttling, a continuous monitor of Erk activity that links it to cell cycle progression.

Authors:  Lionel Le Gallic; Laura Virgilio; Philip Cohen; Benoit Biteau; George Mavrothalassitis
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

2.  Binding of calmodulin to the carboxy-terminal region of p21 induces nuclear accumulation via inhibition of protein kinase C-mediated phosphorylation of Ser153.

Authors:  Aina Rodríguez-Vilarrupla; Montserrat Jaumot; Neus Abella; Núria Canela; Sonia Brun; Carmen Díaz; Josep M Estanyol; Oriol Bachs; Neus Agell
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

3.  Competitive nuclear export of cyclin D1 and Hic-5 regulates anchorage dependence of cell growth and survival.

Authors:  Kazunori Mori; Etsuko Hirao; Yosuke Toya; Yukiko Oshima; Fumihiro Ishikawa; Kiyoshi Nose; Motoko Shibanuma
Journal:  Mol Biol Cell       Date:  2008-10-22       Impact factor: 4.138

4.  Nuclear export of Ho endonuclease of yeast via Msn5.

Authors:  Anya Bakhrat; Keren Baranes-Bachar; Dan Reshef; Olga Voloshin; Oleg Krichevsky; Dina Raveh
Journal:  Curr Genet       Date:  2008-09-20       Impact factor: 3.886

Review 5.  In the wrong place at the wrong time: does cyclin mislocalization drive oncogenic transformation?

Authors:  Jonathan D Moore
Journal:  Nat Rev Cancer       Date:  2013-02-07       Impact factor: 60.716

6.  Competing memories of mitogen and p53 signalling control cell-cycle entry.

Authors:  Hee Won Yang; Mingyu Chung; Takamasa Kudo; Tobias Meyer
Journal:  Nature       Date:  2017-09-06       Impact factor: 49.962

Review 7.  Cyclin D1, cancer progression, and opportunities in cancer treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  J Mol Med (Berl)       Date:  2016-10-02       Impact factor: 4.599

8.  The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.

Authors:  Sabine Paternot; Bianca Colleoni; Xavier Bisteau; Pierre P Roger
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 9.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

Review 10.  Oncogenic role of p21 in hepatocarcinogenesis suggests a new treatment strategy.

Authors:  Shogo Ohkoshi; Masahiko Yano; Yasunobu Matsuda
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.